期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

抑郁症维持治疗为何半途而废 被引量：2

原文传递
导出
摘要 抑郁症在药物治疗控制急性症状后，需要巩固疗效和预防复发，这已是多数专家的共识。一般认为，急性期治疗应尽量达到临床痊愈，其后至少有6-8个月的巩固期药物治疗；再以后需进行2-3年的药物维持治疗。发作次数愈多，则维持治疗时间也应愈长。药物治疗的停药率及停药前用药时间是某些精神药物长期效应的重要评估指标。
作者 姚芳传
机构地区 南京医科大学附属脑科医院
出处 《中华精神科杂志》 CAS CSCD 北大核心 2008年第2期113-113,共1页 Chinese Journal of Psychiatry
关键词 药物维持治疗 抑郁症 药物治疗 急性期治疗 急性症状 预防复发 临床痊愈 发作次数
分类号 R686 [医药卫生—骨科学]
  • 相关文献

参考文献6

  • 1昂秋青,张明园.停药率和停药前用药时间是抗精神病药长期效应的重要评估指标[J].中华精神科杂志,2007,40(1):1-4. 被引量：18
  • 2姚芳传.抗精神病药长期效应的评估指标——读者来信[J].临床精神医学杂志,2007,17(4):288-288. 被引量：2
  • 3Davis SM, Koch GG, Davis CE, et al. Statistical approaches to effectiveness measurement and outcome-driven re-randomizations in the clinical antipsychotic trials of intervention effectiveness (CATIE) studies. Schizophr Bull, 2003, 29:73-80.
  • 4Swartz MS, Perkins DO, Stroup TS, et al. Assessing clinical and functional outcomes in the clinical antipsychotic trials of intervention effectiveness (CATIE) schizophrenia trial. Schizophr Bull, 2003, 29:33-43.
  • 5Lehman AF, Lieberman JA, Dixon LB, et al. Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry, 2004, 161(2 Suppl) :1-56.
  • 6Cramer JA, Rosenheck R. Compliance with medication regimens for mental and physical disorders. Psychiatr Serv, 1998, 49 : 196- 201.

二级参考文献20

  • 1Davis SM, Koch GG, Davis CE, et al. Statistical approaches to effectiveness measurement and outcome-driven re-randomizations in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) studies. Schizophr Bull, 2003,29 : 73-80.
  • 2Swartz MS, Perkins DO, Stroup TS, et al. Assessing clinical and functional outcomes in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial. Schizophr Bull, 2003, 29 : 33- 43.
  • 3Jeste DV, Palmer BW, Harris MJ. Neuroleptic discontinuation in clinical and research settings: scientific issues and cthical dilemmas. Biol Psychiatry, 1999, 46: 1050-1059.
  • 4Woerner MG, Robinson DG, Alvir JM, et al. Clozapine as a first treatment for schizophrenia. Am J Psychiatry, 2003, 160: 1514-1516.
  • 5Gibson PJ, Damler R, Jackson EA, et al. The impact of olanzapine, risperidone, or haloperidol on the cost of schizophrenia care in a medicaid population. Value Health, 2004, 7: 22-35.
  • 6Rosenheck R, Doyle J, Leslie D, et al. Changing environments and alternative perspectives in evaluating the cost-effectiveness of new antipsychotic drugs. Schizophr Bull, 2003, 29: 81-93.
  • 7Stauffer VL, Beasley CM, Liu-Seifert H, et al. Overall treatment effectiveness in schizophrenia-spectrum disorders as measured by time continuing on antipsychotic therapy. Schizophr Bull, 2005,31 : 504-508.
  • 8Kinon B J, Liu-Seifert H, Adams DH, et al. Differential rates of treatment discontinuation in clinical trials as a measure of treatment effectiveness for olanzapine and comparator atypical antipsychotics for schizophrenia. J Clin Psychopharmacol, 2006, 26 : 632-637.
  • 9Lieberman JA, Stroup TS, McEvoy JP, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med, 2005, 353: 1209-1223.
  • 10Ascher-Svanum H, Zhu B, Faries D, et al. Time to discontinuation of atypical venus typical antipsychoties in the naturalistic treatment of schizophrenia. BMC Psychiatry, 2006, 6 :8.

共引文献17

同被引文献4

  • 1Frank E. Enhancing patient outcomes: Treatment adherence[J]. J Clin Psychiatry, 19 9 7,5 6 ( 1 ) : 4- 8.
  • 2Battels S J, Coakley E H, Zubritsky C, et al. Improving access to geri- atric mental health services:A randomized trial comparing treatment engagement with integrated versus enhanced referral care for depres- sion,anxiety, and at - risk alcohol use [J ]. Am J Psychiatry, 2004, 161 (8) : 1455-1462.
  • 3朱凤艳,尚兰,吉中孚.抗精神病药治疗的依从性[J].国外医学（精神病学分册）,2000,27(3):155-158. 被引量：52
  • 4肖世富.抑郁症的中国社区康复模式[J].中国临床康复,2002,6(17):2513-2513. 被引量：16

引证文献2

二级引证文献8

中华精神科杂志
2008年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部